Abstract：OBJECTIVE: To investigate the effect of insulin-like growth factor-1 (IGF-1), which can promote cell differentiation and inhibit cell apoptosis, on hyperoxia-induced apoptosis in A549 cells and its anti-apoptotic mechanism. METHODS: A549 cells were sub-cultured, exposed to hyperoxic conditions and were then treated with different concentrations of IGF-1 (1, 10, and 100 ng/mL) for 48 hours. Cell viability was measured by MTT assay. Cell apoptosis was evaluated by Annexin V-FITC/PI double-staining flow cytometry. Expression levels of Bax and Bcl-2 were measured by flow cytometry. RESULTS: The middle-dose and high-dose IGF-1 intervention groups had higher cell viabilities than the hyperoxic exposure group ［(64±3）% and (88±4)% vs (51±3)%; P<0.05］. Compared with the air control group, the hyperoxic exposure group had a significantly higher apoptotic rate ［(38.3±5.4)% vs (2.4±0.9）%; P<0.05］, a significantly lower expression level of Bcl-2 ［(72±5)% vs (91±4)%; P<0.05］, and a significantly higher expression level of Bax ［(54±6)% vs (3±2)%; P<0.05］. Compared with the hyperoxic exposure group, the low-dose, middle-dose, and high-dose IGF-1 intervention groups had significantly lower apoptotic rates ［(16.1±4.7)%, (9.2±2.8)%, and (6.9±2.5)% vs (38.3±5.4)%; P<0.05］, significantly higher expression level of Bcl-2 ［(79±4)%, (94±4)%, and (100±5)% vs (72±5)%; P<0.05］, and significantly lower expression level of Bax ［(26±4)%, (5±2)%, and (4±2)% vs (54±6)%; P<0.05］. CONCLUSIONS: Hyperoxia significantly inhibits proliferation and promotes apoptosis in A549 cells. IGF-1 may promote cell proliferation and inhibit hyperoxia-induced apoptosis in A549 cells by regulating the expression of Bcl-2 and Bax.
JIN Zhen-Ai,ZHAO Yi-Kun,JIN Zheng-Yong et al. Effect of insulin-like growth factor-1 on hyperoxia-induced apoptosis in A549 cells[J]. CJCP, 2013, 15(6): 490-493.
［2］Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type Ⅱalveolar epithelial cells［J］. Int J Cancer, 1976, 17(1): 62-70.
［3］Park S, Lee YK, Jung M, Kim KH, Chung N, Ahn EK, et al. Cellular toxicity of various inhalable metal Nano-Particles on human alveolar epithelial cells［J］. Inhal Toxicol, 2007, 19(1): 59-65.
［4］Tian D, Zhu M, Li J, Ma Y, Wu R.Cigarette smoke extract induces activation of beta-catenin/TCF signaling through inhibiting GSK3beta in human alveolar epithelial cell line［J］. Toxicol Lett, 2009, 187(1): 58-62.
［12］Hebishima T, Matsumoto Y, Watanabe G, Soma G, Kohchi C, Taya K, et al. Oral administration of immunopotentiator from pantoea agglomerans 1 (IP-PA1) improves the survival of B16 melanoma-inoculated Model mice［J］. Exp Anim, 2011, 60(2):101-109.
［15］Sun F, Liu JY, He F, Liu Z, Wang R, Wang DM, et al. In-vitro antitumor activity evaluation of hyperforin derivatives［J］. J Asian Nat Prod Res, 2011, 13(8): 688-699.
［16］Yang L, Zhou X, Yang J, Yin X, Han L, Zhao D. Aspirin inhibits cytotoxicity of peptide PrP106-126 to neuronal cells asscoiated with microglia activation in vitro［J］. J Neuroimmunol, 2008, 199(1-2): 10-17.
［17］Gradilone A, Gazzaniga P, Ribuffo D, Scarpa S, Cigna E, Vasaturo F, et al. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients［J］.J Clin Oncol, 2003, 21(2): 306-312.
